HEADER CELL CYCLE 10-SEP-15 5AOK TITLE STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE TITLE 2 PHIKAN7099 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELLULAR TUMOR ANTIGEN P53; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: DNA-BINDING DOMAIN, UNP RESIDUES 94-312; COMPND 5 SYNONYM: ANTIGEN NY-CO-13, PHOSPHOPROTEIN P53, TUMOR SUPPRESSOR P53, COMPND 6 P53; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CELL CYCLE, P53, CANCER, TUMOR SUPPRESSION, DNA BINDING, CANCER KEYWDS 2 THERAPY, SMALL-MOLECULE STABILIZERS, MOLECULAR CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR A.C.JOERGER REVDAT 4 10-JAN-24 5AOK 1 REMARK LINK REVDAT 3 15-MAY-19 5AOK 1 REMARK REVDAT 2 08-MAY-19 5AOK 1 REMARK REVDAT 1 16-DEC-15 5AOK 0 JRNL AUTH A.C.JOERGER,M.R.BAUER,R.WILCKEN,M.G.J.BAUD,H.HARBRECHT, JRNL AUTH 2 T.E.EXNER,F.M.BOECKLER,J.SPENCER,A.R.FERSHT JRNL TITL EXPLOITING TRANSIENT PROTEIN STATES FOR THE DESIGN OF JRNL TITL 2 SMALL-MOLECULE STABILIZERS OF MUTANT P53. JRNL REF STRUCTURE V. 23 2246 2015 JRNL REFN ISSN 0969-2126 JRNL PMID 26636255 JRNL DOI 10.1016/J.STR.2015.10.016 REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 103279 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.146 REMARK 3 R VALUE (WORKING SET) : 0.145 REMARK 3 FREE R VALUE : 0.169 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.4273 - 4.1909 0.97 3587 157 0.1637 0.1469 REMARK 3 2 4.1909 - 3.3279 0.98 3444 178 0.1454 0.1727 REMARK 3 3 3.3279 - 2.9077 0.98 3413 164 0.1554 0.1804 REMARK 3 4 2.9077 - 2.6420 0.99 3383 176 0.1566 0.1750 REMARK 3 5 2.6420 - 2.4527 0.98 3391 175 0.1527 0.1601 REMARK 3 6 2.4527 - 2.3082 0.98 3353 168 0.1484 0.1695 REMARK 3 7 2.3082 - 2.1926 0.98 3342 162 0.1452 0.1751 REMARK 3 8 2.1926 - 2.0972 0.98 3306 191 0.1436 0.1770 REMARK 3 9 2.0972 - 2.0165 0.98 3348 176 0.1402 0.1514 REMARK 3 10 2.0165 - 1.9469 0.97 3309 163 0.1336 0.1518 REMARK 3 11 1.9469 - 1.8861 0.97 3301 170 0.1293 0.1876 REMARK 3 12 1.8861 - 1.8321 0.97 3271 195 0.1319 0.1614 REMARK 3 13 1.8321 - 1.7839 0.97 3224 196 0.1207 0.1464 REMARK 3 14 1.7839 - 1.7404 0.97 3254 183 0.1140 0.1479 REMARK 3 15 1.7404 - 1.7008 0.96 3244 177 0.1180 0.1467 REMARK 3 16 1.7008 - 1.6647 0.96 3234 178 0.1187 0.1584 REMARK 3 17 1.6647 - 1.6314 0.96 3242 176 0.1206 0.1540 REMARK 3 18 1.6314 - 1.6006 0.96 3248 183 0.1224 0.1600 REMARK 3 19 1.6006 - 1.5720 0.96 3194 188 0.1267 0.1624 REMARK 3 20 1.5720 - 1.5453 0.95 3217 154 0.1287 0.1667 REMARK 3 21 1.5453 - 1.5204 0.95 3203 183 0.1318 0.1665 REMARK 3 22 1.5204 - 1.4970 0.95 3181 176 0.1342 0.1704 REMARK 3 23 1.4970 - 1.4750 0.95 3221 163 0.1311 0.1844 REMARK 3 24 1.4750 - 1.4542 0.95 3192 147 0.1374 0.1981 REMARK 3 25 1.4542 - 1.4346 0.94 3200 160 0.1493 0.1679 REMARK 3 26 1.4346 - 1.4160 0.95 3168 164 0.1627 0.2218 REMARK 3 27 1.4160 - 1.3983 0.94 3178 156 0.1692 0.1966 REMARK 3 28 1.3983 - 1.3814 0.95 3197 156 0.1805 0.2009 REMARK 3 29 1.3814 - 1.3653 0.94 3108 196 0.2000 0.2352 REMARK 3 30 1.3653 - 1.3500 0.93 3143 172 0.2090 0.2694 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.600 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 3323 REMARK 3 ANGLE : 1.076 4532 REMARK 3 CHIRALITY : 0.045 490 REMARK 3 PLANARITY : 0.007 599 REMARK 3 DIHEDRAL : 13.780 1300 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AOK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1290064972. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0163 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 103354 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 29.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 2J1X REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING-DROP VAPOR DIFFUSION AT 21 REMARK 280 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM REMARK 280 PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 REMARK 280 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. REMARK 280 SOAKING BUFFER: 38 MM COMPOUND IN 100 MM HEPES, PH 7.2, 10 MM REMARK 280 SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 REMARK 280 % (V/V) GLYCEROL, 150 MM KCL., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.50650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.58850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.49450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.58850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.50650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.49450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 94 REMARK 465 SER A 95 REMARK 465 LYS A 291 REMARK 465 LYS A 292 REMARK 465 GLY A 293 REMARK 465 GLU A 294 REMARK 465 PRO A 295 REMARK 465 HIS A 296 REMARK 465 HIS A 297 REMARK 465 GLU A 298 REMARK 465 LEU A 299 REMARK 465 PRO A 300 REMARK 465 PRO A 301 REMARK 465 GLY A 302 REMARK 465 SER A 303 REMARK 465 THR A 304 REMARK 465 LYS A 305 REMARK 465 ARG A 306 REMARK 465 ALA A 307 REMARK 465 LEU A 308 REMARK 465 PRO A 309 REMARK 465 ASN A 310 REMARK 465 ASN A 311 REMARK 465 THR A 312 REMARK 465 LYS B 292 REMARK 465 GLY B 293 REMARK 465 GLU B 294 REMARK 465 PRO B 295 REMARK 465 HIS B 296 REMARK 465 HIS B 297 REMARK 465 GLU B 298 REMARK 465 LEU B 299 REMARK 465 PRO B 300 REMARK 465 PRO B 301 REMARK 465 GLY B 302 REMARK 465 SER B 303 REMARK 465 THR B 304 REMARK 465 LYS B 305 REMARK 465 ARG B 306 REMARK 465 ALA B 307 REMARK 465 LEU B 308 REMARK 465 PRO B 309 REMARK 465 ASN B 310 REMARK 465 ASN B 311 REMARK 465 THR B 312 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2075 O HOH A 2076 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 188 -46.83 -134.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1313 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 176 SG REMARK 620 2 HIS A 179 ND1 106.3 REMARK 620 3 CYS A 238 SG 109.8 102.7 REMARK 620 4 CYS A 238 SG 108.8 127.1 27.6 REMARK 620 5 CYS A 242 SG 110.5 105.6 120.7 97.8 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1300 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 176 SG REMARK 620 2 HIS B 179 ND1 104.9 REMARK 620 3 CYS B 238 SG 110.9 107.3 REMARK 620 4 CYS B 242 SG 110.8 105.9 116.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1291 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1313 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1292 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 1293 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOH A 1292 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOH B 1294 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AOI RELATED DB: PDB REMARK 900 STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH AN INDOLE- REMARK 900 BASED SMALL MOLECULE REMARK 900 RELATED ID: 5AOJ RELATED DB: PDB REMARK 900 STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH 2-HYDROXY- REMARK 900 3,5-DIIODO-4-(1H-PYRROL-1-YL) BENZOIC ACID REMARK 900 RELATED ID: 5AOL RELATED DB: PDB REMARK 900 STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND 3-BROMO-5- REMARK 900 (TRIFLUOROMETHYL)BENZENE-1,2-DIAMINE REMARK 900 RELATED ID: 5AOM RELATED DB: PDB REMARK 900 STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE REMARK 900 PHIKAN883 DBREF 5AOK A 94 312 UNP P04637 P53_HUMAN 94 312 DBREF 5AOK B 94 312 UNP P04637 P53_HUMAN 94 312 SEQADV 5AOK LEU A 133 UNP P04637 MET 133 ENGINEERED MUTATION SEQADV 5AOK ALA A 203 UNP P04637 VAL 203 ENGINEERED MUTATION SEQADV 5AOK CYS A 220 UNP P04637 TYR 220 ENGINEERED MUTATION SEQADV 5AOK TYR A 239 UNP P04637 ASN 239 ENGINEERED MUTATION SEQADV 5AOK ASP A 268 UNP P04637 ASN 268 ENGINEERED MUTATION SEQADV 5AOK LEU B 133 UNP P04637 MET 133 ENGINEERED MUTATION SEQADV 5AOK ALA B 203 UNP P04637 VAL 203 ENGINEERED MUTATION SEQADV 5AOK CYS B 220 UNP P04637 TYR 220 ENGINEERED MUTATION SEQADV 5AOK TYR B 239 UNP P04637 ASN 239 ENGINEERED MUTATION SEQADV 5AOK ASP B 268 UNP P04637 ASN 268 ENGINEERED MUTATION SEQRES 1 A 219 SER SER SER VAL PRO SER GLN LYS THR TYR GLN GLY SER SEQRES 2 A 219 TYR GLY PHE ARG LEU GLY PHE LEU HIS SER GLY THR ALA SEQRES 3 A 219 LYS SER VAL THR CYS THR TYR SER PRO ALA LEU ASN LYS SEQRES 4 A 219 LEU PHE CYS GLN LEU ALA LYS THR CYS PRO VAL GLN LEU SEQRES 5 A 219 TRP VAL ASP SER THR PRO PRO PRO GLY THR ARG VAL ARG SEQRES 6 A 219 ALA MET ALA ILE TYR LYS GLN SER GLN HIS MET THR GLU SEQRES 7 A 219 VAL VAL ARG ARG CYS PRO HIS HIS GLU ARG CYS SER ASP SEQRES 8 A 219 SER ASP GLY LEU ALA PRO PRO GLN HIS LEU ILE ARG VAL SEQRES 9 A 219 GLU GLY ASN LEU ARG ALA GLU TYR LEU ASP ASP ARG ASN SEQRES 10 A 219 THR PHE ARG HIS SER VAL VAL VAL PRO CYS GLU PRO PRO SEQRES 11 A 219 GLU VAL GLY SER ASP CYS THR THR ILE HIS TYR ASN TYR SEQRES 12 A 219 MET CYS TYR SER SER CYS MET GLY GLY MET ASN ARG ARG SEQRES 13 A 219 PRO ILE LEU THR ILE ILE THR LEU GLU ASP SER SER GLY SEQRES 14 A 219 ASN LEU LEU GLY ARG ASP SER PHE GLU VAL ARG VAL CYS SEQRES 15 A 219 ALA CYS PRO GLY ARG ASP ARG ARG THR GLU GLU GLU ASN SEQRES 16 A 219 LEU ARG LYS LYS GLY GLU PRO HIS HIS GLU LEU PRO PRO SEQRES 17 A 219 GLY SER THR LYS ARG ALA LEU PRO ASN ASN THR SEQRES 1 B 219 SER SER SER VAL PRO SER GLN LYS THR TYR GLN GLY SER SEQRES 2 B 219 TYR GLY PHE ARG LEU GLY PHE LEU HIS SER GLY THR ALA SEQRES 3 B 219 LYS SER VAL THR CYS THR TYR SER PRO ALA LEU ASN LYS SEQRES 4 B 219 LEU PHE CYS GLN LEU ALA LYS THR CYS PRO VAL GLN LEU SEQRES 5 B 219 TRP VAL ASP SER THR PRO PRO PRO GLY THR ARG VAL ARG SEQRES 6 B 219 ALA MET ALA ILE TYR LYS GLN SER GLN HIS MET THR GLU SEQRES 7 B 219 VAL VAL ARG ARG CYS PRO HIS HIS GLU ARG CYS SER ASP SEQRES 8 B 219 SER ASP GLY LEU ALA PRO PRO GLN HIS LEU ILE ARG VAL SEQRES 9 B 219 GLU GLY ASN LEU ARG ALA GLU TYR LEU ASP ASP ARG ASN SEQRES 10 B 219 THR PHE ARG HIS SER VAL VAL VAL PRO CYS GLU PRO PRO SEQRES 11 B 219 GLU VAL GLY SER ASP CYS THR THR ILE HIS TYR ASN TYR SEQRES 12 B 219 MET CYS TYR SER SER CYS MET GLY GLY MET ASN ARG ARG SEQRES 13 B 219 PRO ILE LEU THR ILE ILE THR LEU GLU ASP SER SER GLY SEQRES 14 B 219 ASN LEU LEU GLY ARG ASP SER PHE GLU VAL ARG VAL CYS SEQRES 15 B 219 ALA CYS PRO GLY ARG ASP ARG ARG THR GLU GLU GLU ASN SEQRES 16 B 219 LEU ARG LYS LYS GLY GLU PRO HIS HIS GLU LEU PRO PRO SEQRES 17 B 219 GLY SER THR LYS ARG ALA LEU PRO ASN ASN THR HET ZN A1313 1 HET GOL A1291 6 HET GOH A1292 18 HET ZN B1300 1 HET GOL B1292 6 HET PEG B1293 7 HET GOH B1294 18 HETNAM ZN ZINC ION HETNAM GOL GLYCEROL HETNAM GOH 5-[2-CYCLOPROPYL-5-(1H-PYRROL-1-YL)-1,3-OXAZOL-4-YL]- HETNAM 2 GOH 1H-1,2,3,4-TETRAZOLE HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 5 GOH 2(C11 H10 N6 O) FORMUL 8 PEG C4 H10 O3 FORMUL 10 HOH *566(H2 O) HELIX 1 1 GLN A 165 MET A 169 5 5 HELIX 2 2 HIS A 178 CYS A 182 5 5 HELIX 3 3 CYS A 277 ARG A 290 1 14 HELIX 4 4 HIS B 178 CYS B 182 5 5 HELIX 5 5 CYS B 277 LYS B 291 1 15 SHEET 1 AA 4 ARG A 110 GLY A 112 0 SHEET 2 AA 4 CYS A 141 TRP A 146 -1 O GLN A 144 N GLY A 112 SHEET 3 AA 4 THR A 230 TYR A 236 -1 O THR A 230 N LEU A 145 SHEET 4 AA 4 ILE A 195 VAL A 197 -1 O ARG A 196 N ASN A 235 SHEET 1 AB 7 CYS A 124 SER A 127 0 SHEET 2 AB 7 LYS A 132 CYS A 135 -1 O LYS A 132 N SER A 127 SHEET 3 AB 7 LEU A 264 VAL A 274 1 O GLU A 271 N LEU A 133 SHEET 4 AB 7 ILE A 251 GLU A 258 -1 O ILE A 251 N VAL A 272 SHEET 5 AB 7 ARG A 156 TYR A 163 -1 O ARG A 156 N GLU A 258 SHEET 6 AB 7 HIS A 214 PRO A 219 -1 O VAL A 216 N ALA A 159 SHEET 7 AB 7 GLU A 204 ASP A 207 -1 O GLU A 204 N VAL A 217 SHEET 1 BA 4 ARG B 110 GLY B 112 0 SHEET 2 BA 4 CYS B 141 TRP B 146 -1 O GLN B 144 N GLY B 112 SHEET 3 BA 4 THR B 230 TYR B 236 -1 O THR B 230 N LEU B 145 SHEET 4 BA 4 ILE B 195 VAL B 197 -1 O ARG B 196 N ASN B 235 SHEET 1 BB 7 CYS B 124 SER B 127 0 SHEET 2 BB 7 LYS B 132 CYS B 135 -1 O LYS B 132 N SER B 127 SHEET 3 BB 7 LEU B 264 VAL B 274 1 O GLU B 271 N LEU B 133 SHEET 4 BB 7 ILE B 251 GLU B 258 -1 O ILE B 251 N VAL B 272 SHEET 5 BB 7 ARG B 156 TYR B 163 -1 O ARG B 156 N GLU B 258 SHEET 6 BB 7 HIS B 214 PRO B 219 -1 O VAL B 216 N ALA B 159 SHEET 7 BB 7 GLU B 204 ASP B 207 -1 O GLU B 204 N VAL B 217 LINK SG CYS A 176 ZN ZN A1313 1555 1555 2.33 LINK ND1 HIS A 179 ZN ZN A1313 1555 1555 2.01 LINK SG ACYS A 238 ZN ZN A1313 1555 1555 2.38 LINK SG BCYS A 238 ZN ZN A1313 1555 1555 2.22 LINK SG CYS A 242 ZN ZN A1313 1555 1555 2.31 LINK SG CYS B 176 ZN ZN B1300 1555 1555 2.33 LINK ND1 HIS B 179 ZN ZN B1300 1555 1555 2.04 LINK SG CYS B 238 ZN ZN B1300 1555 1555 2.32 LINK SG CYS B 242 ZN ZN B1300 1555 1555 2.30 SITE 1 AC1 8 PRO A 219 GLU A 221 THR A 230 THR A 231 SITE 2 AC1 8 ILE A 232 GOH A1292 HOH A2212 HOH A2213 SITE 1 AC2 4 CYS A 176 HIS A 179 CYS A 238 CYS A 242 SITE 1 AC3 9 PRO B 219 CYS B 220 GLU B 221 THR B 230 SITE 2 AC3 9 THR B 231 ILE B 232 GOH B1294 HOH B2196 SITE 3 AC3 9 HOH B2197 SITE 1 AC4 4 HIS B 115 SER B 116 GLY B 117 ARG B 282 SITE 1 AC5 4 CYS B 176 HIS B 179 CYS B 238 CYS B 242 SITE 1 AC6 12 VAL A 147 THR A 150 PRO A 151 CYS A 220 SITE 2 AC6 12 GLU A 221 PRO A 223 THR A 230 GOL A1291 SITE 3 AC6 12 HOH A2094 HOH A2095 HOH A2107 HOH A2288 SITE 1 AC7 14 VAL B 147 THR B 150 PRO B 151 PRO B 152 SITE 2 AC7 14 CYS B 220 GLU B 221 PRO B 223 THR B 230 SITE 3 AC7 14 GOL B1292 HOH B2082 HOH B2083 HOH B2084 SITE 4 AC7 14 HOH B2097 HOH B2278 CRYST1 65.013 70.989 105.177 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015382 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014087 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009508 0.00000